A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1

A key issue for the study of tuberculosis infection (TB) is to understand why individuals infected with Mycobacterium tuberculosis experience different clinical outcomes. Elaborating the immune mechanisms that determine whether an infected individual will suffer active TB or latent infection can aid in developing treatment and prevention strategies. To better understand the dynamics of M. tuberculosis infection and immunity, we have developed a virtual human model that qualitatively and quantitatively characterizes the cellular and cytokine control network operational during TB infection. Using this model, we identify key regulatory elements in the host response. In particular, factors affecting cell functions, such as macrophage activation and bactericidal capabilities, and effector T cell functions such as cytotoxicity and cytokine production can each be determinative. The model indicates, however, that even if latency is achieved, it may come at the expense of tissue damage if the response is not properly regulated. A balance in Th1 and Th2 immune responses governed by IFN-γ, IL-10, and IL-4 facilitate this down-regulation. These results are further explored through virtual deletion and depletion experiments.

[1]  J. Sprent,et al.  Lifespan of lymphocytes , 1995, Immunologic research.

[2]  H. Gan,et al.  Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-alpha activity. , 1999, The Journal of infectious diseases.

[3]  Malin,et al.  Human cytolytic and interferon g-secreting CD 8 1 T lymphocytes specific for Mycobacterium tuberculosis , 1997 .

[4]  R. Young,et al.  Increased Antimycobacterial Immunity in Interleukin-10-Deficient Mice , 1999, Infection and Immunity.

[5]  S. Giosué,et al.  Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. , 1999, American journal of respiratory and critical care medicine.

[6]  S. Kira,et al.  Prognostic value of Ia+ T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis. , 1996, American journal of respiratory and critical care medicine.

[7]  P. Schlesinger,et al.  Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. , 1994, Science.

[8]  B. Samten,et al.  Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. , 1999, The Journal of infectious diseases.

[9]  S. Reed,et al.  Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. , 1998, Journal of immunology.

[10]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[11]  G. V. van Seventer,et al.  Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals. , 1997, Journal of immunology.

[12]  E. Radwanski,et al.  Pharmacodynamics of subcutaneous recombinant human interleukin‐10 in healthy volunteers , 1997, Clinical pharmacology and therapeutics.

[13]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[14]  N. Rao,et al.  Yield of gastric lavage and bronchial wash in pulmonary tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  J. Ho,et al.  Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. , 1998, Journal of immunology.

[16]  A. Scheffold,et al.  Commitment of individual Th1-like lymphocytes to expression of IFN-gamma versus IL-4 and IL-10: selective induction of IL-10 by sequential stimulation of naive Th cells with IL-12 and IL-4. , 1998, Journal of immunology.

[17]  R. de Waal Malefyt,et al.  IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. , 1992, Journal of immunology.

[18]  A S Perelson,et al.  Role of the thymus in pediatric HIV-1 infection. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[19]  R. Kurzrock,et al.  Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. , 1985, Cancer research.

[20]  Z. Toossi,et al.  Regulation of Interleukin-12 by Interleukin-10, Transforming Growth Factor-β, Tumor Necrosis Factor-α, and Interferon-γ in Human Monocytes Infected with Mycobacterium tuberculosis H37Ra , 1998 .

[21]  M. de Carli,et al.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. , 1993, Journal of immunology.

[22]  B. Hamilton,et al.  Interaction of Mycobacterium tuberculosis-Induced Transforming Growth Factor β1 and Interleukin-10 , 1999, Infection and Immunity.

[23]  I. Orme,et al.  Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[24]  H. Dockrell,et al.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Blaser,et al.  Theoretical and experimental approaches for studying factors defining the Helicobacter pylori-host relationship. , 2000, Trends in microbiology.

[26]  P. Haslett,et al.  Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. , 1999, Journal of immunology.

[27]  B. Hemmer,et al.  Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. , 1997, Journal of immunology.

[28]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[29]  A. Izzo,et al.  Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity , 1993, The Journal of experimental medicine.

[30]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[31]  K. Croitoru,et al.  Protection by CD4 or CD8 T Cells against PulmonaryMycobacterium bovis Bacillus Calmette-Guérin Infection , 1998, Infection and Immunity.

[32]  J. Flynn,et al.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.

[33]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[34]  W. Boom,et al.  Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. , 1997, Journal of immunology.

[35]  F. Miedema,et al.  IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. , 1996, Journal of immunology.

[36]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[37]  G. Puzo,et al.  Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. , 1997, Journal of immunology.

[38]  G. Galluccio,et al.  Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. , 1998, American journal of respiratory and critical care medicine.

[39]  C. Mody,et al.  Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. , 1999, American journal of respiratory and critical care medicine.

[40]  J. Wang,et al.  Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. , 1998, Journal of immunology.

[41]  S. Kaufmann,et al.  Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages , 1997, Infection and immunity.

[42]  U. Lalloo,et al.  Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)α levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis , 2000, Thorax.

[43]  S. Kunkel,et al.  In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. , 1995, Journal of immunology.

[44]  W. Rom,et al.  Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. , 1996, American journal of respiratory and critical care medicine.

[45]  S. Kaufmann,et al.  Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor , 1990, Infection and immunity.

[46]  M. Blaser,et al.  Persistent bacterial infections , 2000 .

[47]  J. Sprent Lifespans of naive, memory and effector lymphocytes. , 1993, Current opinion in immunology.

[48]  C. Janeway Immunobiology: The Immune System in Health and Disease , 1996 .

[49]  M. Olivier,et al.  TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.

[50]  R. Flavell,et al.  Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. , 1997, Journal of immunology.

[51]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[52]  J. Keane,et al.  Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis , 1997, Infection and immunity.

[53]  P. Morel,et al.  Modeling the proliferative response of T cells to IL-2 and IL-4. , 1997, Cellular immunology.

[54]  P. Barnes,et al.  Growth of Virulent and AvirulentMycobacterium tuberculosis Strains in Human Macrophages , 1998, Infection and Immunity.

[55]  J. Banchereau,et al.  Interferon gamma inhibits interleukin 10 production by monocytes , 1993, The Journal of experimental medicine.

[56]  Sergei S. Pilyugin,et al.  Modeling immune responses with handling time , 2000, Bulletin of mathematical biology.

[57]  Norman L. Cressy The Tubercle Bacillus in the Pulmonary Lesion of Man , 1955, The Yale Journal of Biology and Medicine.

[58]  E. Block,et al.  Clinical role of bronchoalveolar lavage in adults with pulmonary disease. , 1990, The American review of respiratory disease.

[59]  C. Ellis,et al.  Specific lysis of mycobacterial antigen‐bearing macrophages by class II MHC‐restricted polyclonal T cell lines in healthy donors or patients with tuberculosis , 1990, Clinical and experimental immunology.

[60]  R. North Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.

[61]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[62]  P. Linsley,et al.  Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.

[63]  S. Meddows-Taylor,et al.  Dysregulated Production of Interleukin-8 in Individuals Infected with Human Immunodeficiency Virus Type 1 andMycobacterium tuberculosis , 1999, Infection and Immunity.

[64]  P. Barnes,et al.  Absence of a prominent Th2 cytokine response in human tuberculosis , 1996, Infection and immunity.

[65]  W. Rom,et al.  Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. , 1996, American journal of respiratory and critical care medicine.

[66]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[67]  M Juchniewicz,et al.  [Epidemiology of tuberculosis]. , 1970, Pielegniarka i polozna.

[68]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[69]  R. Young,et al.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.

[70]  R. Stout,et al.  Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. , 1989, Journal of immunology.

[71]  B. Bloom,et al.  Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993 .

[72]  D. Remick,et al.  Cytokines in Health and Disease , 1992 .

[73]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[74]  G. Kaplan,et al.  Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. , 1996, The Journal of infectious diseases.

[75]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[76]  马建新,et al.  用FEV6.0代替FVC诊断气道阻塞和肺功能受限[英]/Swanney MP…∥Am J Respir Crit Care Med. , 2002 .

[77]  J. Ceuppens,et al.  Interleukin 12 and B7/CD28 interaction synergistically upregulate interleukin 10 production by human T cells. , 1997, Cytokine.

[78]  W. Rom,et al.  Local immune responses correlate with presentation and outcome in tuberculosis. , 1998, American journal of respiratory and critical care medicine.

[79]  P. Bardin,et al.  In Situ Production of Gamma Interferon, Interleukin-4, and Tumor Necrosis Factor Alpha mRNA in Human Lung Tuberculous Granulomas , 2000, Infection and Immunity.

[80]  Z. Toossi,et al.  Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. , 1998, American journal of respiratory cell and molecular biology.

[81]  J. Blanchard,et al.  Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. , 1999, Journal of immunology.

[82]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[83]  G. Rook,et al.  Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. , 2000, The Journal of infectious diseases.

[84]  J. D. de Vries,et al.  Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level , 1996, The Journal of experimental medicine.

[85]  G. Ainslie,et al.  Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. , 1992, Thorax.

[86]  A S Perelson,et al.  Th1/Th2 cross regulation. , 1993, Journal of theoretical biology.

[87]  B. Bloom,et al.  Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993, Infection and immunity.

[88]  Y. Luo,et al.  Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin. , 1999, Journal of immunology.

[89]  J. Ellner,et al.  Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. , 1998, Journal of immunology.

[90]  H. Macdonald,et al.  Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. , 1998, Journal of immunology.

[91]  E. Radwanski,et al.  Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. , 1996, Blood.

[92]  M. Gately,et al.  Interleukin 12 at the site of disease in tuberculosis. , 1994, The Journal of clinical investigation.

[93]  M. Burdick,et al.  Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. , 1993, Journal of immunology.

[94]  M. de Carli,et al.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.

[95]  J. Ellner,et al.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.

[96]  J. Sedgwick,et al.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.

[97]  P. Gros,et al.  Consequence of Nramp1 Deletion toMycobacterium tuberculosis Infection in Mice , 1999, Infection and Immunity.

[98]  Glenn F. Webb,et al.  Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. , 2000 .

[99]  D. Kirschner,et al.  Dynamics of co-infection with M. Tuberculosis and HIV-1. , 1999, Theoretical population biology.

[100]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[101]  J. Abrams,et al.  T-cell cytokine responses in human infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[102]  J. Meer,et al.  Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. , 2000, The Journal of infectious diseases.

[103]  M. Torres,et al.  Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. , 1998, The Journal of infectious diseases.

[104]  J. Keane,et al.  Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. , 1998, Journal of immunology.

[105]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[106]  H. Dockrell,et al.  Characterization of Human Mycobacterium bovis Bacille Calmette-Guérin-Reactive CD8+T Cells , 1999, Infection and Immunity.

[107]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[108]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[109]  D. Kirschner,et al.  Mathematical Models of Colonization and Persistence in Bacterial Infections , 2000 .

[110]  F. Balkwill Cytokines in health and disease. , 1993, Immunology today.

[111]  J. Flynn,et al.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.

[112]  P. Schlesinger,et al.  Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. , 1998, Journal of immunology.

[113]  Savageau Ma,et al.  Reconstructionist molecular biology. , 1991 .

[114]  W. Boom,et al.  CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. , 1995, Journal of immunology.

[115]  J. Flynn,et al.  Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.

[116]  J. Flynn,et al.  Early Emergence of CD8+ T Cells Primed for Production of Type 1 Cytokines in the Lungs of Mycobacterium tuberculosis-Infected Mice , 1999, Infection and Immunity.

[117]  R. Kurzrock,et al.  Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant γ-lnterferon in Cancer Patients , 1985 .

[118]  Hardy Kornfeld,et al.  Virulent Mycobacterium tuberculosis Strains Evade Apoptosis of Infected Alveolar Macrophages1 , 2000, The Journal of Immunology.

[119]  J. Abrams,et al.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.

[120]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[121]  J. Ellner,et al.  Expression of Virulence of Mycobacterium tuberculosiswithin Human Monocytes: Virulence Correlates with Intracellular Growth and Induction of Tumor Necrosis Factor Alpha but Not with Evasion of Lymphocyte-Dependent Monocyte Effector Functions , 1998, Infection and Immunity.

[122]  J. Flynn,et al.  CD8+ CTL from Lungs of Mycobacterium tuberculosis-Infected Mice Express Perforin In Vivo and Lyse Infected Macrophages1 , 2000, The Journal of Immunology.

[123]  T. Kotsimbos,et al.  IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. , 1997, American journal of respiratory and critical care medicine.

[124]  P. D. Hart,et al.  RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.

[125]  M A Savageau,et al.  Reconstructionist molecular biology. , 1991, The New biologist.

[126]  W. Boom,et al.  Differential Regulation of IFN-γ, TNF-α, and IL-10 Production by CD4+ αβTCR+ T Cells and Vδ2+ γδ T Cells in Response to Monocytes Infected with Mycobacterium tuberculosis-H37Ra , 1999 .

[127]  L. Segel,et al.  On the role of feedback in promoting conflicting goals of the adaptive immune system. , 1999, Journal of immunology.

[128]  M. Piacentini,et al.  APOPTOSIS OF HUMAN MONOCYTES/MACROPHAGES IN MYCOBACTERIUM TUBERCULOSIS INFECTION , 1997, The Journal of pathology.

[129]  L. Nicod,et al.  Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. , 1999, American journal of respiratory cell and molecular biology.

[130]  A. O’Garra,et al.  Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.

[131]  J. Watson,et al.  Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis , 1997, Infection and immunity.

[132]  J. Neefjes,et al.  Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and Recycling , 1997 .

[133]  Sato,et al.  Differential potentiation of anti‐mycobacterial activity and reactive nitrogen intermediate‐producing ability of murine peritoneal macrophages activated by interferon‐gamma (IFN‐γ) and tumour necrosis factor‐alpha (TNF‐α) , 1998, Clinical and experimental immunology.

[134]  W. Boom,et al.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis , 1996, Infection and immunity.

[135]  R. van Furth,et al.  QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTION , 1973, The Journal of experimental medicine.

[136]  J. Sprent,et al.  Circulating T and B lymphocytes of the mouse. II. Lifespan. , 1973, Cellular immunology.

[137]  Q. Myrvik,et al.  Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence. , 1984, The American review of respiratory disease.